Divergent Immune Pathways in Coronary Artery Disease and Aortic Stenosis: The Role of Chronic Inflammation and Senescence.

Journal: International journal of molecular sciences
Published Date:

Abstract

Coronary artery disease (CAD) remains a major cause of cardiovascular morbidity and mortality, with growing evidence linking immune dysregulation to its pathogenesis. Aortic stenosis often coexists with CAD (ASCAD), representing an advanced disease form. This study investigates immune pathways in isolated CAD (iCAD) and ASCAD. For this purpose, peripheral blood from 72 individuals (healthy donors, iCAD, and ASCAD patients) was analysed via flow cytometry to assess immune populations. Circulating cytokine levels were measured, and machine learning models identified predictive immune biomarkers. Our data showed that both iCAD and ASCAD patients exhibited immune dysregulation, with reduced dendritic cells, basophils, NK cells, B cells, and T cells, alongside lower frequencies of DCs, lymphocytes, CD8+CD28+ T cells, and CD57+ T cells. Elevated IL-15 and fractalkine, but reduced IL-8 and MCP-1, suggest impaired monocyte and neutrophil mobilisation due to immune cell sequestration in vascular lesions. Distinct immune features emerged between iCAD and ASCAD. iCAD patients showed heightened immune activation, with increased inflammatory CD14+CD16+ monocytes, higher Treg frequencies, and greater CD4+ T cell differentiation into TEM and TEMRA phenotypes. In contrast, ASCAD patients exhibited pronounced immunosenescence, with higher neutrophil counts, lymphopenia, and increased NK and T cell cytotoxicity. Our predictive model distinguished iCAD from ASCAD with high accuracy, identifying CD4+ T cell memory subsets and CD57 expression as key discriminators. This study reveals iCAD as being driven by immune activation and ASCAD by immunosenescence and cytotoxicity. These insights advance CAD immunopathology understanding and support immune-based classification, particularly for ASCAD, where treatment remains limited to surgical intervention.

Authors

  • José Joaquín Domínguez-Del-Castillo
    Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Pablo Álvarez-Heredia
    Immunology and Allergy Group (GC01), Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Irene Reina-Alfonso
    Immunology and Allergy Group (GC01), Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Maria-Isabel Vallejo-Bermúdez
    Immunology and Allergy Group (GC01), Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Rosalía López-Romero
    Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Jose Antonio Moreno-Moreno
    Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Lucía Bilbao-Carrasco
    Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Javier Moya-Gonzalez
    Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • María Muñoz-Calero
    Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Raquel Tarazona
    Immunology Unit, Department of Physiology, University of Extremadura, 10003 Cáceres, Spain.
  • Rafael Solana
    Department of Cell Biology, Physiology and Immunology, University of Cordoba, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Alexander Batista-Duharte
    Department of Cell Biology, Physiology and Immunology, University of Cordoba, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Ignacio Muñoz
    Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
  • Alejandra Pera
    Department of Cell Biology, Physiology and Immunology, University of Cordoba, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.